Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280007
Status:
TERMINATED
Last Update Posted:
2010-04-22
First Post:
2006-01-19
Brief Title:
Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Organization Data
Organization:
Medical University of Vienna
Class:
OTHER
Study ID:
MPR-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of Vienna
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Markus Peck-Radosavljevic M D
Old Organization:
Medizinische Universität Wien